Corporate Profile

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. More >>

Recent NewsMore >>
Rhythm Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
Rhythm Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference
Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
RYTM (Common Stock) $22.830.00 (0.00%)06/17/19 4:00 p.m. ET
Stock chart for: RYTM.O.  Currently trading at $22.83 with a 52 week high of $37.23 and a 52 week low of $22.02.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Upcoming EventsMore >>
There are currently no events scheduled.